125 related articles for article (PubMed ID: 30677774)
1. Roles of 12-Lipoxygenase and Its Interaction with Angiotensin II on p21 and p27 Expression in Diabetic Nephropathy.
Zhang YY; Wang WN; Su SS; Chen B; Sun WX; Wu H; Cheng YL; Xu ZG
Nephron; 2019; 142(1):61-70. PubMed ID: 30677774
[TBL] [Abstract][Full Text] [Related]
2. p16ink4a Expression Is Increased through 12-Lipoxygenase in High Glucose-Stimulated Glomerular Mesangial Cells and Type 2 Diabetic Glomeruli.
Zhang YY; Guo QY; Wu MY; Zang CS; Ma FZ; Sun T; Wang WN; Miao LN; Xu ZG
Nephron; 2015; 130(2):141-50. PubMed ID: 26022507
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M
Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735
[TBL] [Abstract][Full Text] [Related]
4. 12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance.
Xu HZ; Cheng YL; Wang WN; Wu H; Zhang YY; Zang CS; Xu ZG
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164093
[TBL] [Abstract][Full Text] [Related]
5. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG
J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232
[TBL] [Abstract][Full Text] [Related]
6. 12-Lipoxygenase as a key pharmacological target in the pathogenesis of diabetic nephropathy.
Dong C; Liu S; Cui Y; Guo Q
Eur J Pharmacol; 2020 Jul; 879():173122. PubMed ID: 32333927
[TBL] [Abstract][Full Text] [Related]
7. Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats.
Guo QY; Miao LN; Li B; Ma FZ; Liu N; Cai L; Xu ZG
Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E708-16. PubMed ID: 21285403
[TBL] [Abstract][Full Text] [Related]
8. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells.
Reddy MA; Adler SG; Kim YS; Lanting L; Rossi J; Kang SW; Nadler JL; Shahed A; Natarajan R
Am J Physiol Renal Physiol; 2002 Nov; 283(5):F985-94. PubMed ID: 12372774
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
[TBL] [Abstract][Full Text] [Related]
10. Products of 12/15-lipoxygenase upregulate the angiotensin II receptor.
Xu ZG; Yuan H; Lanting L; Li SL; Wang M; Shanmugam N; Kato M; Adler SG; Reddy MA; Natarajan R
J Am Soc Nephrol; 2008 Mar; 19(3):559-69. PubMed ID: 18235084
[TBL] [Abstract][Full Text] [Related]
11. Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy.
Xu ZG; Li SL; Lanting L; Kim YS; Shanmugam N; Reddy MA; Natarajan R
Kidney Int; 2006 Feb; 69(3):512-9. PubMed ID: 16514433
[TBL] [Abstract][Full Text] [Related]
12. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy.
Yuan H; Reddy MA; Deshpande S; Jia Y; Park JT; Lanting LL; Jin W; Kato M; Xu ZG; Das S; Natarajan R
Antioxid Redox Signal; 2016 Mar; 24(7):361-75. PubMed ID: 26492974
[TBL] [Abstract][Full Text] [Related]
14. Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes.
Kang SW; Natarajan R; Shahed A; Nast CC; LaPage J; Mundel P; Kashtan C; Adler SG
J Am Soc Nephrol; 2003 Dec; 14(12):3178-87. PubMed ID: 14638916
[TBL] [Abstract][Full Text] [Related]
15. 12-lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy.
Kang SW; Adler SG; Nast CC; LaPage J; Gu JL; Nadler JL; Natarajan R
Kidney Int; 2001 Apr; 59(4):1354-62. PubMed ID: 11260396
[TBL] [Abstract][Full Text] [Related]
16. Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice.
Kim YS; Reddy MA; Lanting L; Adler SG; Natarajan R
Kidney Int; 2003 Nov; 64(5):1702-14. PubMed ID: 14531803
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli.
Singh R; Singh AK; Leehey DJ
Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1183-90. PubMed ID: 15701818
[TBL] [Abstract][Full Text] [Related]
18. The cyclin kinase inhibitor p21WAF1, CIP1 is increased in experimental diabetic nephropathy: potential role in glomerular hypertrophy.
Kuan CJ; al-Douahji M; Shankland SJ
J Am Soc Nephrol; 1998 Jun; 9(6):986-93. PubMed ID: 9621281
[TBL] [Abstract][Full Text] [Related]
19. The lack of cyclin kinase inhibitor p27(Kip1) ameliorates progression of diabetic nephropathy.
Awazu M; Omori S; Ishikura K; Hida M; Fujita H
J Am Soc Nephrol; 2003 Mar; 14(3):699-708. PubMed ID: 12595506
[TBL] [Abstract][Full Text] [Related]
20. [The role of cyclin-dependent kinase inhibitors in hyperplasia and hypertrophy of vascular smooth muscle cells].
Xu D; Wang M; Liu Y
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):680-3. PubMed ID: 11798949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
